Key Record Dates
| ClinicalTrials.gov Identifier: | NCT02472145 |
|---|---|
| Brief Title: | An Efficacy and Safety Study of Decitabine (DACOGEN) Plus Talacotuzumab (JNJ-56022473; Anti CD123) Versus Decitabine (DACOGEN) Alone in Participants With Acute Myeloid Leukemia (AML) Ineligible for Intensive Chemotherapy |
| First Submitted : | April 29, 2015 |
| First Submitted that Met QC Criteria : | June 10, 2015 |
| First Posted : | June 15, 2015 (Estimate) |
| Results First Submitted : | January 24, 2019 |
| Results First Submitted that Met QC Criteria : | February 27, 2019 |
| Results First Posted : | February 28, 2019 |
| Last Update Submitted that Met QC Criteria : | March 11, 2019 |
| Last Update Posted : | March 19, 2019 |